Jing Xiang1, Shiqin Huang1, Youlin Tuo2, Yun Wang3. 1. Department of Outpatient, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science & Technology of China, Chengdu, China. 2. Department of Breast Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science & Technology of China, Chengdu, China. 3. Department of Neurology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science & Technology of China, Chengdu, China.
Abstract
BACKGROUND: As one of the main malignant tumors, breast cancer remains a worldwide public health issue. Here, we aimed to analyze the effects of breast-conserving surgery (BCS) combined with sentinel lymph node biopsy (SLNB) and axillary preservation on the recurrence, metastasis, complications, and cosmetic results of early breast cancer patients (BCPs). METHODS: The clinical data of 143 BCPs admitted to our hospital from January 2017 to January 2019 were collected retrospectively, and all patients were female. Patients (76 cases) undergoing BCS combined with SLNB and axillary preservation treatment were set as the combined group, and 67 cases undergoing traditional modified radical surgery were set as the control group. After the perioperative conditions of patients in the two groups were compared, the patients were followed up for 14 months to record information on the quality of life, recurrence, metastasis, complications, and cosmetic results. RESULTS: The operation time, intraoperative blood loss, and extubation time of the combined group were significantly less than the control group (P<0.05); the quality of life of patients in both groups improved after treatment, but the quality of life of patients in the combined group was significantly higher than that of the control group (P<0.05); both groups of patients were followed up for 14 months after treatment, and there were no deaths. The rates of local recurrence and distant metastasis were 2.98% and 5.97% in the control group and 5.26% and 6.57% in the combined group, respectively, showing no significant difference between the two groups (P>0.05); the incidence of postoperative complications was 14.92% in the control group, which was significantly higher than the incidence of 3.94% of the combined group (P<0.05); the proportion of postoperative cosmetic results with an excellent and good rating was 59.7% in the control group, which was significantly lower than the 93.42% reported in the combined group (P<0.05). CONCLUSIONS: BCS combined with SLNB and axillary preservation provided good clinical and cosmetic results and can improve the quality of life of patients and reduce the rate of recurrence and metastasis. 2020 Gland Surgery. All rights reserved.
BACKGROUND: As one of the main malignant tumors, breast cancer remains a worldwide public health issue. Here, we aimed to analyze the effects of breast-conserving surgery (BCS) combined with sentinel lymph node biopsy (SLNB) and axillary preservation on the recurrence, metastasis, complications, and cosmetic results of early breast cancer patients (BCPs). METHODS: The clinical data of 143 BCPs admitted to our hospital from January 2017 to January 2019 were collected retrospectively, and all patients were female. Patients (76 cases) undergoing BCS combined with SLNB and axillary preservation treatment were set as the combined group, and 67 cases undergoing traditional modified radical surgery were set as the control group. After the perioperative conditions of patients in the two groups were compared, the patients were followed up for 14 months to record information on the quality of life, recurrence, metastasis, complications, and cosmetic results. RESULTS: The operation time, intraoperative blood loss, and extubation time of the combined group were significantly less than the control group (P<0.05); the quality of life of patients in both groups improved after treatment, but the quality of life of patients in the combined group was significantly higher than that of the control group (P<0.05); both groups of patients were followed up for 14 months after treatment, and there were no deaths. The rates of local recurrence and distant metastasis were 2.98% and 5.97% in the control group and 5.26% and 6.57% in the combined group, respectively, showing no significant difference between the two groups (P>0.05); the incidence of postoperative complications was 14.92% in the control group, which was significantly higher than the incidence of 3.94% of the combined group (P<0.05); the proportion of postoperative cosmetic results with an excellent and good rating was 59.7% in the control group, which was significantly lower than the 93.42% reported in the combined group (P<0.05). CONCLUSIONS: BCS combined with SLNB and axillary preservation provided good clinical and cosmetic results and can improve the quality of life of patients and reduce the rate of recurrence and metastasis. 2020 Gland Surgery. All rights reserved.
Entities:
Keywords:
Breast-conserving surgery (BCS); complications; early breast cancer; recurrence and metastasis; sentinel lymph node biopsy and axillary preservation
Authors: Lucy De La Cruz; Stephanie A Blankenship; Abhishek Chatterjee; Rula Geha; Nadia Nocera; Brian J Czerniecki; Julia Tchou; Carla S Fisher Journal: Ann Surg Oncol Date: 2016-06-29 Impact factor: 5.344
Authors: W P Weber; S D Soysal; I Fulco; M Barandun; D Babst; D Kalbermatten; D J Schaefer; D Oertli; E A Kappos; M Haug Journal: Eur J Surg Oncol Date: 2017-01-31 Impact factor: 4.424
Authors: David E Wazer; Seth Kaufman; Laurie Cuttino; Thomas DiPetrillo; Douglas W Arthur Journal: Int J Radiat Oncol Biol Phys Date: 2005-10-24 Impact factor: 7.038
Authors: Timothy J Whelan; Jim A Julian; Tanya S Berrang; Do-Hoon Kim; Isabelle Germain; Alan M Nichol; Mohamed Akra; Sophie Lavertu; Francois Germain; Anthony Fyles; Theresa Trotter; Francisco E Perera; Susan Balkwill; Susan Chafe; Thomas McGowan; Thierry Muanza; Wayne A Beckham; Boon H Chua; Chu Shu Gu; Mark N Levine; Ivo A Olivotto Journal: Lancet Date: 2019-12-05 Impact factor: 79.321